ALB and lung cancer: A recent study described the prognostic significance of advance lung cancer inflammation index (ALI; a systemic inflammation-based index), which was calculated by multiplying body mass index (BMI, kg/m2) by the serum albumin/neutrophil-lymphocyte ratio (NLR).